Sandrone G, Mortara A, Torzillo D, La Rovere M T, Malliani A, Lombardi F
Centro Ricerche Cardiovascolari, CNR, Pavia, Italy.
Am J Cardiol. 1994 Aug 15;74(4):340-5. doi: 10.1016/0002-9149(94)90400-6.
This study analyzed, with spectral techniques, the effects of atenolol or metoprolol on RR interval variability in 20 patients 4 weeks after the first uncomplicated myocardial infarction. Beta blocker-induced bradycardia was associated with a significant increase in the average 24-hour values of RR variance (from 13,886 +/- 1,479 to 16,728 +/- 1,891 ms2) and of the normalized power of the high-frequency component (from 22 +/- 1 to 28 +/- 2 normalized units), whereas the low-frequency component was greatly reduced (from 60 +/- 3 to 50 +/- 3 normalized units). When considering day and nighttime separately, the effects of both drugs were more pronounced in the daytime. In addition, a marked attenuation was observed in the circadian variation of the low-frequency component after beta blockade. As a result, the early morning increase of the spectral index of sympathetic modulation was no longer detectable. These results indicate that beta-blocker administration has important effects on RR interval variability and on its spectral components. The observed reduction in signs of sympathetic activation and the increase in vagal tone after beta blockade help to explain the beneficial effects of these drugs after myocardial infarction. However, the potential clinical relevance of the increase in RR variance remains to be established.
本研究采用频谱技术分析了阿替洛尔或美托洛尔对20例首次发生无并发症心肌梗死后4周患者RR间期变异性的影响。β受体阻滞剂所致的心动过缓与RR间期方差的24小时平均值显著增加(从13,886±1,479增至16,728±1,891 ms2)以及高频成分标准化功率增加(从22±1增至28±2标准化单位)相关,而低频成分则大幅降低(从60±3降至50±3标准化单位)。当分别考虑白天和夜间时,两种药物的作用在白天更为明显。此外,β受体阻滞剂治疗后低频成分的昼夜变化明显减弱。结果,不再能检测到交感神经调制频谱指数的清晨升高。这些结果表明,给予β受体阻滞剂对RR间期变异性及其频谱成分有重要影响。β受体阻滞剂治疗后观察到的交感神经激活征象减少和迷走神经张力增加有助于解释这些药物在心肌梗死后的有益作用。然而,RR间期方差增加的潜在临床相关性仍有待确定。